Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Hematol Oncol Clin North Am. 2018 Aug;32(4):657–668. doi: 10.1016/j.hoc.2018.04.002

Figure 1.

Figure 1

Fanconi Triple Assessment: Patients being evaluated for Fanconi anemia require a triple assessment including: (A) history/physical, (B) clastogenic testing or chromosomal breakage testing with diepoxybutane +/− mitomycin C, and (C) genetic testing.